價(jià)格 | 詢價(jià) | ||
包裝 | 100ug | 500ug | 1000ug |
最小起訂量 | 100ug |
發(fā)貨地 | 北京 |
更新日期 | 2024-12-16 |
中文名稱:CD64蛋白 | 英文名稱:CD64 |
品牌: 百普賽斯 | 產(chǎn)地: 北京 |
保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
產(chǎn)品類別: 重組蛋白 | |
貨號(hào): CD64 | 用途范圍: 藥物開發(fā)等 |
規(guī)格: 100ug | 是否進(jìn)口: 否 |
分子別名(Synonym)
FCGR1A,FCG1,FCGR1,IGFR1,CD64,CD64A,FCRI
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD64, His Tag (FCA-H52H1) is expressed from human 293 cells (HEK293). It contains AA Gln 16 - Leu 281 (Accession # P12314-1).
Predicted N-terminus: Gln 16
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 31.8 kDa. The protein migrates as 45-60 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.
背景(Background)
識(shí)別IgG Fc部分的受體分為三組,分別稱為Fcγ-RI、RII和RIII,也分別稱為CD64、CD32和CD16。Fc-gamma RI以高親和力結(jié)合IgG,并在早期免疫反應(yīng)中發(fā)揮作用。Fc-gamma RII和RIII是低親和力受體,在晚期免疫應(yīng)答期間將IgG識(shí)別為多價(jià)抗原周圍的聚集體。
高親和力免疫球蛋白γ-Fc受體I也稱為FCGR1A、FCG1、FCGR1、CD64和IGFR1,是一種以高親和力結(jié)合單體IgG型抗體的完整膜糖蛋白,屬于免疫球蛋白超家族或FCGR1家族。FCGR1A/CD64含有3個(gè)Ig樣C2型(免疫球蛋白樣)結(jié)構(gòu)域。CD64僅在巨噬細(xì)胞和單核細(xì)胞上存在,但用IFNγ和G-CSF等細(xì)胞因子處理多形核白細(xì)胞可以誘導(dǎo)CD64在這些細(xì)胞上表達(dá)。
成立日期 | 2010-07-22 (15年) | 注冊(cè)資本 | 8000萬人民幣 |
員工人數(shù) | 500人以上 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥3260 |
VIP4年
|
上海博爾森生物科技有限公司
|
2024-12-31 | |
詢價(jià) |
VIP3年
|
武漢佰樂博生物技術(shù)有限公司
|
2024-12-27 | |
¥1098 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2024-12-31 |